Hillan Kenneth J. 4
4 · 23andMe Holding Co. · Filed Aug 25, 2022
Insider Transaction Report
Form 4
Hillan Kenneth
Head of Therapeutics
Transactions
- Sale
Class A Common Stock
2022-08-24$3.64/sh−8,753$31,861→ 196,083 total
4 · 23andMe Holding Co. · Filed Aug 25, 2022
Class A Common Stock